But these clinical trial numbers likely undercount the true frequency because many mild reactions go unreported
The timing, frequency, and extent of senescent cell removal remain open questions (for example, when is it best to clear them? What is the rebound or regenerative consequence?)
The company is investigating tirzepatide in patients with overweight and obesity who do not have type 2 diabetes, with Mounjaro poised to add the hot indication of chronic weight management to its label by the end of this year
Dai L, Niu D, Huang JW, Li X, Shen P, Li H, Xie Z, Min J, Hu Y, Yang Y et al (2023) Cryo-EM structure and rational engineering of a superefficient ochratoxin A-detoxifying amidohydrolase
I remind them that any increase in exercise is good and can help control A1C and weightand improve the health of their eyes